Towards Non-Targeted Screening of Lipid Biomarkers for Improved Equine Anti-Doping

The current approach to equine anti-doping is focused on the targeted detection of prohibited substances. However, as new substances are rapidly being developed, the need for complimentary methods for monitoring is crucial to ensure the integrity of the racing industry is upheld. Lipidomics is a gro...

Full description

Bibliographic Details
Main Authors: Kathy Tou, Adam Cawley, Christopher Bowen, David P. Bishop, Shanlin Fu
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/28/1/312
_version_ 1797440333972242432
author Kathy Tou
Adam Cawley
Christopher Bowen
David P. Bishop
Shanlin Fu
author_facet Kathy Tou
Adam Cawley
Christopher Bowen
David P. Bishop
Shanlin Fu
author_sort Kathy Tou
collection DOAJ
description The current approach to equine anti-doping is focused on the targeted detection of prohibited substances. However, as new substances are rapidly being developed, the need for complimentary methods for monitoring is crucial to ensure the integrity of the racing industry is upheld. Lipidomics is a growing field involved in the characterisation of lipids, their function and metabolism in a biological system. Different lipids have various biological effects throughout the equine system including platelet aggregation and inflammation. A certain class of lipids that are being reviewed are the eicosanoids (inflammatory markers). The use of eicosanoids as a complementary method for monitoring has become increasingly popular with various studies completed to highlight their potential. Studies including various corticosteroids, non-steroidal anti-inflammatories and cannabidiol have been reviewed to highlight the progress lipidomics has had in contributing to the equine anti-doping industry. This review has explored the techniques used to prepare and analyse samples for lipidomic investigations in addition to the statistical analysis and potential for lipidomics to be used for a longitudinal assessment in the equine anti-doping industry.
first_indexed 2024-03-09T12:05:41Z
format Article
id doaj.art-660294f0ebaf43db969fa006a6ce2d38
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-09T12:05:41Z
publishDate 2022-12-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-660294f0ebaf43db969fa006a6ce2d382023-11-30T22:57:53ZengMDPI AGMolecules1420-30492022-12-0128131210.3390/molecules28010312Towards Non-Targeted Screening of Lipid Biomarkers for Improved Equine Anti-DopingKathy Tou0Adam Cawley1Christopher Bowen2David P. Bishop3Shanlin Fu4Centre for Forensic Science, University of Technology Sydney, Sydney, NSW 2007, AustraliaAustralian Racing Forensic Laboratory, Racing NSW, Sydney, NSW 2000, AustraliaMass Spectrometry Business Unit, Shimadzu Scientific Instruments (Australasia), Sydney, NSW 2116, AustraliaHyphenated Mass Spectrometry Laboratory (HyMAS), University of Technology, Sydney, NSW 2007, AustraliaCentre for Forensic Science, University of Technology Sydney, Sydney, NSW 2007, AustraliaThe current approach to equine anti-doping is focused on the targeted detection of prohibited substances. However, as new substances are rapidly being developed, the need for complimentary methods for monitoring is crucial to ensure the integrity of the racing industry is upheld. Lipidomics is a growing field involved in the characterisation of lipids, their function and metabolism in a biological system. Different lipids have various biological effects throughout the equine system including platelet aggregation and inflammation. A certain class of lipids that are being reviewed are the eicosanoids (inflammatory markers). The use of eicosanoids as a complementary method for monitoring has become increasingly popular with various studies completed to highlight their potential. Studies including various corticosteroids, non-steroidal anti-inflammatories and cannabidiol have been reviewed to highlight the progress lipidomics has had in contributing to the equine anti-doping industry. This review has explored the techniques used to prepare and analyse samples for lipidomic investigations in addition to the statistical analysis and potential for lipidomics to be used for a longitudinal assessment in the equine anti-doping industry.https://www.mdpi.com/1420-3049/28/1/312lipidomicsreviewanalyticalcorticosteroidsNSAIDs
spellingShingle Kathy Tou
Adam Cawley
Christopher Bowen
David P. Bishop
Shanlin Fu
Towards Non-Targeted Screening of Lipid Biomarkers for Improved Equine Anti-Doping
Molecules
lipidomics
review
analytical
corticosteroids
NSAIDs
title Towards Non-Targeted Screening of Lipid Biomarkers for Improved Equine Anti-Doping
title_full Towards Non-Targeted Screening of Lipid Biomarkers for Improved Equine Anti-Doping
title_fullStr Towards Non-Targeted Screening of Lipid Biomarkers for Improved Equine Anti-Doping
title_full_unstemmed Towards Non-Targeted Screening of Lipid Biomarkers for Improved Equine Anti-Doping
title_short Towards Non-Targeted Screening of Lipid Biomarkers for Improved Equine Anti-Doping
title_sort towards non targeted screening of lipid biomarkers for improved equine anti doping
topic lipidomics
review
analytical
corticosteroids
NSAIDs
url https://www.mdpi.com/1420-3049/28/1/312
work_keys_str_mv AT kathytou towardsnontargetedscreeningoflipidbiomarkersforimprovedequineantidoping
AT adamcawley towardsnontargetedscreeningoflipidbiomarkersforimprovedequineantidoping
AT christopherbowen towardsnontargetedscreeningoflipidbiomarkersforimprovedequineantidoping
AT davidpbishop towardsnontargetedscreeningoflipidbiomarkersforimprovedequineantidoping
AT shanlinfu towardsnontargetedscreeningoflipidbiomarkersforimprovedequineantidoping